These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 12563424)

  • 1. Addition of exogenous cytokines in mixed lymphocyte culture for selecting related donors for bone marrow transplantation.
    Visentainer JE; Lieber SR; Persoli Lg; Vigorito AC; Aranha FJ; Souza Cr
    Sao Paulo Med J; 2002 Nov; 120(6):175-9. PubMed ID: 12563424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alloreactivity and the predictive value of anti-recipient specific interleukin 2 producing helper T lymphocyte precursor frequencies for alloreactivity after bone marrow transplantation.
    Russell CA
    Dan Med Bull; 2002 May; 49(2):89-108. PubMed ID: 12064093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the mixed lymphocyte culture (MLC) assay as a method for selecting unrelated donors for marrow transplantation.
    Mickelson EM; Longton G; Anasetti C; Petersdorf E; Martin P; Guthrie LA; Hansen JA
    Tissue Antigens; 1996 Jan; 47(1):27-36. PubMed ID: 8929710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Positivity in a modified mixed leukocyte reaction test correlates with molecular HLA-C disparity in prediction of unrelated bone marrow transplantation outcome.
    Bishara A; Brautbar C; Cohen I; Nagler A
    Hum Immunol; 1999 Sep; 60(9):833-9. PubMed ID: 10527390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transplantation-related complications predicted by cytokine gene expression in the mixed lymphocyte culture in allogeneic bone marrow transplants.
    Tanaka J; Imamura M; Kasai M; Sakurada K
    Leuk Lymphoma; 1995 Sep; 19(1-2):27-32. PubMed ID: 8574169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of the mixed lymphocyte culture (MLC) reaction in marrow donor selection: matching for transplants from related haploidentical donors.
    Mickelson EM; Guthrie LA; Etzioni R; Anasetti C; Martin PJ; Hansen JA
    Tissue Antigens; 1994 Aug; 44(2):83-92. PubMed ID: 7817382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of correlation of MLC reactivity with acute graft-versus-host disease and mortality in unrelated donor bone marrow transplantation.
    Segall M; Noreen H; Edwins L; Haake R; Shu XO; Kersey J
    Hum Immunol; 1996 Aug; 49(1):49-55. PubMed ID: 8839775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytokine gene expression in the mixed lymphocyte culture in allogenic bone marrow transplants as a predictive method for transplantation-related complications.
    Tanaka J; Imamura M; Kasai M; Kobayashi S; Hashino S; Kobayashi H; Sakurada K; Miyazaki T
    Br J Haematol; 1994 Jun; 87(2):415-8. PubMed ID: 7947291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of pretransplant donor anti-recipient cytotoxic and helper T lymphocyte responses as correlates of acute graft-vs.-host disease and survival after unrelated marrow transplantation.
    Pei J; Martin PJ; Longton G; Masewicz S; Mickelson E; Petersdorf E; Anasetti C; Hansen J
    Biol Blood Marrow Transplant; 1997 Aug; 3(3):142-9. PubMed ID: 9310191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Significance and features of MLC reaction in histocompatibility determination of donor and recipient in allogenic bone marrow transplantation to patients with hematological malignancies].
    Shpakova AP; Bulycheva TI; Liubimova LS; Mendeleeva LP
    Ter Arkh; 2000; 72(11):62-7. PubMed ID: 11229316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mixed leukocyte culture reactivity and graft-versus-host disease in HLA-identical marrow transplantation for leukemia.
    DeGast GC; Mickelson EM; Beatty PG; Amos D; Sullivan KM; Schoch HG; Thomas ED; Hansen JA
    Bone Marrow Transplant; 1992 Feb; 9(2):87-90. PubMed ID: 1533333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Donor helper T-cell frequencies as predictors of acute graft-versus-host disease in bone marrow transplantation between HLA-identical siblings.
    Weston LE; Geczy AF; Farrell C
    Transplantation; 1997 Sep; 64(6):836-41. PubMed ID: 9326407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential effects of the absence of interferon-gamma and IL-4 in acute graft-versus-host disease after allogeneic bone marrow transplantation in mice.
    Murphy WJ; Welniak LA; Taub DD; Wiltrout RH; Taylor PA; Vallera DA; Kopf M; Young H; Longo DL; Blazar BR
    J Clin Invest; 1998 Nov; 102(9):1742-8. PubMed ID: 9802888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Mixed lympho-epidermal cell cultures: value in bone marrow grafts].
    Bagot M; Kuentz M; Mary JY; Heslan M; Cordonnier C; Rochant H; Dubertret L; Levy JP; Vernant JP
    Presse Med; 1989 Mar; 18(12):629-33. PubMed ID: 2524732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Donor alloreactivity may predict acute graft-versus-host disease in patients receiving marrow transplants from HLA identical siblings.
    Johnsen HE; Mickelson E; Beatty PG; Hansen JA
    Bone Marrow Transplant; 1992 Feb; 9(2):91-6. PubMed ID: 1533334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between interleukin-4-producing T lymphocyte frequencies and reduced risk of graft-versus-host disease.
    Imami N; Brookes PA; Lombardi G; Hakooz B; Johns M; Goldman JM; Batchelor JR; Lechler RI; Ritter MA
    Transplantation; 1998 Apr; 65(7):979-88. PubMed ID: 9565104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-2 inhibits early increases in serum gamma interferon levels associated with graft-versus-host-disease.
    Szebeni J; Wang MG; Pearson DA; Szot GL; Sykes M
    Transplantation; 1994 Dec; 58(12):1385-93. PubMed ID: 7809932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoreactivity, backstimulation and reproducibility in a helper T lymphocyte precursor assay.
    Russell CA; Petersen SL; Heilmann C; Madsen HO; Vindeløv LL
    J Immunol Methods; 2001 May; 251(1-2):109-21. PubMed ID: 11292487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction by a modified mixed leukocyte reaction assay of graft-versus-host disease and graft rejection after allogeneic bone marrow transplantation.
    Bishara A; Brautbar C; Nagler A; Slavin S; Leshem B; Cohen I; Kedar E
    Transplantation; 1994 May; 57(10):1474-9. PubMed ID: 8197610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Donor specific bone marrow cells suppress lymphocyte reactivity to donor antigens and differentially modulate TH1 and TH2 cytokine gene expression in the responder cell population.
    Lagoo-Deenadayalan S; Lagoo AS; Lemons JA; Lorenz HM; Bass JD; McDaniel DO; Hardy KJ; Barber WH
    Transpl Immunol; 1995 Jun; 3(2):124-34. PubMed ID: 7582903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.